##gff-version 3
##sequence-region Q9H8Y5 1 726
Q9H8Y5	UniProtKB	Chain	1	726	.	.	.	ID=PRO_0000247278;Note=Ankyrin repeat and zinc finger domain-containing protein 1	
Q9H8Y5	UniProtKB	Repeat	493	526	.	.	.	Note=ANK 1	
Q9H8Y5	UniProtKB	Repeat	534	563	.	.	.	Note=ANK 2	
Q9H8Y5	UniProtKB	Zinc finger	72	96	.	.	.	Note=C2H2-type	
Q9H8Y5	UniProtKB	Region	654	666	.	.	.	Note=VCP/p97-interacting motif (VIM);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21896481;Dbxref=PMID:21896481	
Q9H8Y5	UniProtKB	Coiled coil	609	659	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H8Y5	UniProtKB	Modified residue	258	258	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q9H8Y5	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H8Y5	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
Q9H8Y5	UniProtKB	Modified residue	533	533	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q9H8Y5	UniProtKB	Modified residue	607	607	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q9H8Y5	UniProtKB	Modified residue	675	675	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q9H8Y5	UniProtKB	Modified residue	680	680	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H8Y5	UniProtKB	Natural variant	32	87	.	.	.	ID=VAR_079136;Note=Found in a patient with infantile-onset inflammatory bowel disease%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28302725;Dbxref=PMID:28302725	
Q9H8Y5	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_079137;Note=Found in a patient with infantile-onset inflammatory bowel disease%3B unknown pathological significance%3B decreased function in cellular response to hydrogen peroxide%3B does not affect protein abundance%3B does not affect interaction with VCP. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28302725;Dbxref=dbSNP:rs149382949,PMID:28302725	
Q9H8Y5	UniProtKB	Natural variant	569	569	.	.	.	ID=VAR_048269;Note=R->W;Dbxref=dbSNP:rs2293076	
Q9H8Y5	UniProtKB	Natural variant	585	585	.	.	.	ID=VAR_079138;Note=Found in a patient with infantile-onset inflammatory bowel disease%3B unknown pathological significance%3B decreased function in cellular response to hydrogen peroxide%3B decreased protein abundance%3B does not affect interaction with VCP. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28302725;Dbxref=dbSNP:rs189875478,PMID:28302725	
Q9H8Y5	UniProtKB	Natural variant	638	638	.	.	.	ID=VAR_079139;Note=Q->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28302725;Dbxref=PMID:28302725	
Q9H8Y5	UniProtKB	Natural variant	676	676	.	.	.	ID=VAR_048270;Note=P->L;Dbxref=dbSNP:rs2293079	
Q9H8Y5	UniProtKB	Mutagenesis	661	662	.	.	.	Note=Abolishes interaction with VCP. AA->LL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21896481;Dbxref=PMID:21896481	
